Cargando…
Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy
Poxviruses have been used extensively as vaccine vectors for human and veterinary medicine and have recently entered the clinical realm as immunotherapies for cancer. We present a comprehensive method for producing high-quality lots of the poxvirus Parapoxvirus ovis (OrfV) for use in preclinical mod...
Autores principales: | van Vloten, Jacob P., Minott, Jessica A., McAusland, Thomas M., Ingrao, Joelle C., Santry, Lisa A., McFadden, Grant, Petrik, James J., Bridle, Byram W., Wootton, Sarah K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579082/ https://www.ncbi.nlm.nih.gov/pubmed/34786436 http://dx.doi.org/10.1016/j.omtm.2021.08.004 |
Ejemplares similares
-
Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer
por: Santry, Lisa A., et al.
Publicado: (2017) -
Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019) -
Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer
por: van Vloten, Jacob P, et al.
Publicado: (2022) -
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
por: McAusland, Thomas M., et al.
Publicado: (2021) -
The Role of Neutrophils in Oncolytic Orf Virus-Mediated Cancer Immunotherapy
por: Minott, Jessica A., et al.
Publicado: (2022)